Furthermore, we used 2-deoxy-D-glucose (2DG), a competitor of glucose (which is one of the main substrates used in bioenergetic pathways of cancer cells) to test the dependence of the NPAT-JAK2 and the PAX5-JAK2 transforming potential on bioenergetic rewiring. This evidence concerns the gene JAK2 and cancer.